In a world obsessed with direct-to-consumer health apps, Dermicus is taking the opposite approach: building a secure, enterprise-grade bridge between primary care and remote dermatology specialists. They aren't selling hope to patients; they're selling efficiency to hospitals.

"Dermicus isn't fighting for the consumer wallet; it's fighting for the hospital workflow."

The tech stack—jQuery, Bootstrap, Tailwind CSS—suggests a pragmatic, functional approach rather than bleeding-edge frontend engineering. They are focused on reliability over flash, which is exactly what medical software requires. With a team of 32 generating $6.9M in revenue, they are lean, profitable, and likely cash-flow positive, avoiding the 'growth at all costs' trap that sinks many healthtech startups.

• Niche Domination: They ignore general dermatology to focus on skin cancer and wound management—high-stakes, high-value use cases.
• B2B2C Model: They monetize through healthcare institutions, not end-users, creating sticky, recurring revenue streams.
• Localized Traction: Traffic data suggests strong footholds in specific European markets, likely Sweden, before scaling globally.